Biomarkers in acute heart failure

2021 ◽  
pp. 409-424
Author(s):  
Rajiv Choudhary ◽  
Nicholas Wettersten ◽  
Kevin Shah ◽  
Alan Maisel
Keyword(s):  
Heart Failure ◽  
Health Care ◽  
Acute Heart Failure ◽  
Health Care Systems ◽  
High Sensitivity ◽  
Medical Problem ◽  
National Health Care ◽  
Acute Dyspnoea ◽  
Galectin 3 ◽  
Care Systems

Acute heart failure continues to be a worldwide medical problem, associated with frequent readmissions, high mortality, and a profound economic impact on national health care systems. Biomarkers have shifted the way in which acute heart failure is managed by the cardiologist. The search for the ideal biomarker to aid in the diagnosis, prognosis, and treatment of acute heart failure is ongoing. The natriuretic peptides have come close to an ideal biomarker and prove extremely useful in determining whether acute dyspnoea has a cardiac aetiology. Furthermore, they are useful for prognosis and may have a role in guiding management of heart failure. Additionally, high-sensitivity troponin, sST2, and galectin-3 are increasingly used with mounting clinical evidence for utility. Other emerging acute heart failure biomarkers include mid-regional pro-adrenomedullin, bio-adrenomedulin, mid-regional proatrial natriuretic peptide, and procalcitonin.

Biomarkers in acute heart failure

2015 ◽  
Author(s):  
Rajiv Choudhary ◽  
Kevin Shah ◽  
Alan Maisel
Keyword(s):  
Heart Failure ◽  
Acute Heart Failure ◽  
Natriuretic Peptides ◽  
Health Care Systems ◽  
Medical Problem ◽  
National Health Care ◽  
Neutrophil Gelatinase Associated Lipocalin ◽  
Acute Dyspnoea ◽  
Care Systems ◽  
Neutrophil Gelatinase

Acute heart failure continues to be a worldwide medical problem, associated with frequent readmissions, high mortality, and a profound economic impact on national health care systems. In the past decade, biomarkers have shifted the way in which acute heart failure is managed by the cardiologist. The search for the ideal biomarker to aid in the diagnosis, prognosis, and treatment of acute heart failure is ongoing. The natriuretic peptides have proved extremely useful in determining whether acute dyspnoea has a cardiac aetiology. In addition, recent trials have demonstrated the use of natriuretic peptides in inpatient and outpatient prognosis, as well as in titrating medications in outpatients with chronic heart failure to prevent acute heart failure hospitalizations. Other emerging acute heart failure biomarkers include mid-regional pro-adrenomedullin, mid-regional proatrial natriuretic peptide, troponin, ST2, and neutrophil gelatinase-associated lipocalin.

Biomarkers in acute heart failure

2018 ◽  
Author(s):  
Rajiv Choudhary ◽  
Kevin Shah ◽  
Alan Maisel
Keyword(s):  
Heart Failure ◽  
Acute Heart Failure ◽  
Health Care Systems ◽  
Medical Problem ◽  
National Health Care ◽  
Neutrophil Gelatinase Associated Lipocalin ◽  
Acute Dyspnoea ◽  
Care Systems ◽  
Neutrophil Gelatinase ◽  
The Ideal

Acute heart failure continues to be a worldwide medical problem, associated with frequent readmissions, high mortality, and a profound economic impact on national health care systems. In the past decade, biomarkers have shifted the way in which acute heart failure is managed by the cardiologist. The search for the ideal biomarker to aid in the diagnosis, prognosis, and treatment of acute heart failure is ongoing. The natriureticfc peptides have proved extremely useful in determining whether acute dyspnoea has a cardiac aetiology. In addition, recent trials have demonstrated the use of natriuretic peptides in inpatient and outpatient prognosis, as well as in titrating medications in outpatients with chronic heart failure to prevent acute heart failure hospitalizations. Other emerging acute heart failure biomarkers include mid-regional pro-adrenomedullin, mid-regional proatrial natriuretic peptide, troponin, ST2, and neutrophil gelatinase-associated lipocalin.

Biomarkers in acute heart failure

2017 ◽  
Author(s):  
Rajiv Choudhary ◽  
Kevin Shah ◽  
Alan Maisel
Keyword(s):  
Heart Failure ◽  
Acute Heart Failure ◽  
Health Care Systems ◽  
Medical Problem ◽  
National Health Care ◽  
Neutrophil Gelatinase Associated Lipocalin ◽  
Acute Dyspnoea ◽  
Care Systems ◽  
Neutrophil Gelatinase ◽  
The Ideal

Acute heart failure continues to be a worldwide medical problem, associated with frequent readmissions, high mortality, and a profound economic impact on national health care systems. In the past decade, biomarkers have shifted the way in which acute heart failure is managed by the cardiologist. The search for the ideal biomarker to aid in the diagnosis, prognosis, and treatment of acute heart failure is ongoing. The natriureticfc peptides have proved extremely useful in determining whether acute dyspnoea has a cardiac aetiology. In addition, recent trials have demonstrated the use of natriuretic peptides in inpatient and outpatient prognosis, as well as in titrating medications in outpatients with chronic heart failure to prevent acute heart failure hospitalizations. Other emerging acute heart failure biomarkers include mid-regional pro-adrenomedullin, mid-regional proatrial natriuretic peptide, troponin, ST2, and neutrophil gelatinase-associated lipocalin.

Biomarkers in acute heart failure

2016 ◽  
Author(s):  
Rajiv Choudhary ◽  
Kevin Shah ◽  
Alan Maisel
Keyword(s):  
Heart Failure ◽  
Acute Heart Failure ◽  
Natriuretic Peptides ◽  
Health Care Systems ◽  
Medical Problem ◽  
National Health Care ◽  
Neutrophil Gelatinase Associated Lipocalin ◽  
Acute Dyspnoea ◽  
Care Systems ◽  
Neutrophil Gelatinase

Acute heart failure continues to be a worldwide medical problem, associated with frequent readmissions, high mortality, and a profound economic impact on national health care systems. In the past decade, biomarkers have shifted the way in which acute heart failure is managed by the cardiologist. The search for the ideal biomarker to aid in the diagnosis, prognosis, and treatment of acute heart failure is ongoing. The natriuretic peptides have proved extremely useful in determining whether acute dyspnoea has a cardiac aetiology. In addition, recent trials have demonstrated the use of natriuretic peptides in inpatient and outpatient prognosis, as well as in titrating medications in outpatients with chronic heart failure to prevent acute heart failure hospitalizations. Other emerging acute heart failure biomarkers include mid-regional pro-adrenomedullin, mid-regional proatrial natriuretic peptide, troponin, ST2, and neutrophil gelatinase-associated lipocalin.

scholarly journals The prehospital patient pathway and experience of care with acute heart failure: a comparison of two health care systems

2020 ◽  
Author(s):  
Joseph McCambridge ◽  
Ciara Keane ◽  
Myra Walshe ◽  
Patricia Campbell ◽  
James Heyes ◽  
...  
Keyword(s):  
Heart Failure ◽  
Health Care ◽  
Acute Heart Failure ◽  
Health Care Systems ◽  
Patient Pathway ◽  
Experience Of Care ◽  
Care Systems

Die Bedeutung der EuGH-Rechtsprechung für die Nachfrage nach Gesundheitsleistungen in der EU

2003 ◽  
Vol 52 (3) ◽  
Author(s):  
Jörg Jasper ◽  
Ralf Tostmann
Keyword(s):  
Health Care ◽  
National Health ◽  
Health Care Systems ◽  
Economic Effects ◽  
Advanced Technology ◽  
The European Union ◽  
National Health Care ◽  
European Court ◽  
Care Systems ◽  
Principle Of Territoriality

AbstractIn this paper we analyze the economic effects of the European Court of Justice’s (CoJ’s) jurisdiction on national health care systems in Europe, especially in Germany. We focus on the CoJ’s decisions concerning European patients’ rights to choose freely among suppliers of medical treatment within the European Union. The results are that national health care systems will face an increasing pressure to comply with the rules of the European Treaty. For Germany, this means that some traditional traits of its regulatory framework, especially the principle of territoriality, will have to undergo a test of “Europe-friendliness”. Unlike these qualitative aspects, we find that quantitative effects will remain more or less negligible for the nearer future and will mostly be confined to the sector of advanced technology medicine.

Sign in / Sign up

Export Citation Format

Share Document